- Home
- DYN vs TILE Comparison
DYN vs TILE Comparison
Compare DYN & TILE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- TILE
- Stock Information
- Founded
- DYN 1984
- TILE 1973
- Country
- DYN United States
- TILE United States
- Employees
- DYN N/A
- TILE N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- TILE Home Furnishings
- Sector
- DYN Health Care
- TILE Consumer Discretionary
- Exchange
- DYN Nasdaq
- TILE Nasdaq
- Market Cap
- DYN 1.9B
- TILE 1.6B
- IPO Year
- DYN 2020
- TILE N/A
- Fundamental
- Price
- DYN $14.22
- TILE $28.18
- Analyst Decision
- DYN Strong Buy
- TILE Buy
- Analyst Count
- DYN 14
- TILE 1
- Target Price
- DYN $34.93
- TILE $32.00
- AVG Volume (30 Days)
- DYN 2.4M
- TILE 370.4K
- Earning Date
- DYN 07-28-2025
- TILE 10-31-2025
- Dividend Yield
- DYN N/A
- TILE 0.14%
- EPS Growth
- DYN N/A
- TILE 43.35
- EPS
- DYN N/A
- TILE 1.62
- Revenue
- DYN N/A
- TILE $1,352,215,000.00
- Revenue This Year
- DYN N/A
- TILE $7.40
- Revenue Next Year
- DYN N/A
- TILE $5.17
- P/E Ratio
- DYN N/A
- TILE $17.33
- Revenue Growth
- DYN N/A
- TILE 6.26
- 52 Week Low
- DYN $6.36
- TILE $17.24
- 52 Week High
- DYN $37.08
- TILE $28.32
- Technical
- Relative Strength Index (RSI)
- DYN 73.48
- TILE 70.12
- Support Level
- DYN $13.03
- TILE $26.11
- Resistance Level
- DYN $13.85
- TILE $27.16
- Average True Range (ATR)
- DYN 0.64
- TILE 0.64
- MACD
- DYN 0.04
- TILE -0.06
- Stochastic Oscillator
- DYN 95.55
- TILE 94.36
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.